Close Menu

NEW YORK (GenomeWeb) – Contextual Genomics has signed a deal to offer its Find-It solid tumor test in Brazil through Sao Paulo-based diagnostics firm Idengene, the companies said today.

Find-It is a next-generation sequencing-based multiplex assay that screens 120 hotspots and 17 exons in 33 known cancer genes to help clinicians select the best treatment for a specific patient, recognize acquired drug-resistant mutations, and determine prognostic and diagnostic implications for patient care.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.